ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

NecroX-7 Attenuates Ischemia-Reperfusion Renal Injury.

K. Lee,1 Y. Ham,1 J. Jeon,1 Y. Chang,2 S. Chung,1 K. Na,1 D. Choi.1

1Renal Division, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
2Internal Medicine, Daejeon Saint Mary Hospital, College of Medicine, Catholic University, Daejeon, Korea.

Meeting: 2016 American Transplant Congress

Abstract number: C109

Keywords: Renal injury, Renal ischemia

Session Information

Session Name: Poster Session C: Ischemia Reperfusion Injury and Organ Preservation

Session Type: Poster Session

Date: Monday, June 13, 2016

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Introduction: Recently mitochondrial damage has been known to play a major role in various renal injury mechanisms including ischemia-reperfusion (IR) renal injury. Mitochondrial injury and reactive oxygen species (ROS) generation play a role in IR renal injury. NecroX-7 is recently developed compounds which are concentrated in mitochondria, and reduce mitochondrial reactive oxygen species and improve cell survival. We assessed the effects of NecroX-7 on IR renal injury.

Methods: Ischemic injury was induced by mineral oil on HK-2 cell culture, in vitro. Mitochondrial respiratory complex, membrane potential, and reactive oxygen generation were evaluated in control and ischemic HK-2 cells with or without NecroX-7. Cell survival was also evaluated. C57BL/6 mice (10 weeks old) were divided into 4 groups; vehicle (n=5) and NecroX-7 (10mg/kg intraperitoneal injection) treated sham groups (n=5), vehicle (n=7) and NecroX-7(n=7) treated IR (reperfusion 27 minutes after clamping of both renal arteries and veins) groups. Kidneys and blood were harvested 24hr after IR injury. We performed real time RT-PCR, western blot and immunohistochemistry for molecular study and H&E stain and PAS stain for histologic examination.

Results:

NecroX-7 treatment significantly increased survival of ischemic HK-2 cells. NecroX-7 treatment increased mitochondrial complex IV and oxygen consumption rate. Also it decreased the 3NT and 8-OH deoxyguanosine generation. The levels of BUN and serum creatinine in NecroX7 treated IR injured mice were significantly lower than those of vehicle treated IR injured mice (p <0.05). In microscopic examination, NecroX7 significantly reduced renal tubular epithelial cell necrosis and detachment. NecroX-7 reduced significantly 8-OH deoxyguanosine positive and TUNEL positive cells in IR injured kidneys. Also it significantly decreased the level of Bax/Bcl-2 ratio and phosphorylated caspase -3.

Conclusion: In conclusion, NecroX-7 enhances mitochondrial respiratory complex IV and reduces mitochondrial damage and ROS generation. Also it attenuates ischemia reperfusion renal injury.

CITATION INFORMATION: Lee K, Ham Y, Jeon J, Chang Y, Chung S, Na K, Choi D. NecroX-7 Attenuates Ischemia-Reperfusion Renal Injury. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lee K, Ham Y, Jeon J, Chang Y, Chung S, Na K, Choi D. NecroX-7 Attenuates Ischemia-Reperfusion Renal Injury. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/necrox-7-attenuates-ischemia-reperfusion-renal-injury/. Accessed May 11, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences